Free Trial

Bio-Rad Laboratories (BIO) Competitors

Bio-Rad Laboratories logo
$250.90 +3.84 (+1.55%)
As of 03:59 PM Eastern

BIO vs. MTD, WAT, ILMN, TECH, CRL, BRKR, PACB, HBIO, TMO, and A

Should you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry.

Bio-Rad Laboratories vs. Its Competitors

Bio-Rad Laboratories (NYSE:BIO) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends, institutional ownership and media sentiment.

65.2% of Bio-Rad Laboratories shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 17.8% of Bio-Rad Laboratories shares are owned by insiders. Comparatively, 0.8% of Mettler-Toledo International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Mettler-Toledo International has a net margin of 22.17% compared to Bio-Rad Laboratories' net margin of -85.16%. Bio-Rad Laboratories' return on equity of 4.32% beat Mettler-Toledo International's return on equity.

Company Net Margins Return on Equity Return on Assets
Bio-Rad Laboratories-85.16% 4.32% 3.03%
Mettler-Toledo International 22.17%-556.22%26.27%

Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Rad Laboratories$2.57B2.66-$1.84B-$76.20-3.29
Mettler-Toledo International$3.87B6.47$863.14M$40.1030.09

Bio-Rad Laboratories has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.37, meaning that its stock price is 37% more volatile than the S&P 500.

In the previous week, Mettler-Toledo International had 15 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 19 mentions for Mettler-Toledo International and 4 mentions for Bio-Rad Laboratories. Mettler-Toledo International's average media sentiment score of 1.52 beat Bio-Rad Laboratories' score of 1.26 indicating that Mettler-Toledo International is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bio-Rad Laboratories
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Mettler-Toledo International
15 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Bio-Rad Laboratories presently has a consensus price target of $324.25, indicating a potential upside of 29.23%. Mettler-Toledo International has a consensus price target of $1,282.64, indicating a potential upside of 6.32%. Given Bio-Rad Laboratories' stronger consensus rating and higher possible upside, equities analysts plainly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bio-Rad Laboratories
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75
Mettler-Toledo International
0 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.42

Summary

Mettler-Toledo International beats Bio-Rad Laboratories on 12 of the 16 factors compared between the two stocks.

Get Bio-Rad Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIO vs. The Competition

MetricBio-Rad LaboratoriesMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$6.72B$10.44B$5.47B$20.52B
Dividend YieldN/A2.08%5.25%3.76%
P/E Ratio-3.2916.3327.0027.79
Price / Sales2.6630.64435.7540.48
Price / Cash23.7722.7536.8222.26
Price / Book1.073.657.984.58
Net Income-$1.84B$235.43M$3.16B$982.91M
7 Day Performance1.10%1.77%3.69%1.31%
1 Month Performance13.83%1.59%2.91%4.85%
1 Year Performance-8.82%-9.65%34.30%14.09%

Bio-Rad Laboratories Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIO
Bio-Rad Laboratories
4.8517 of 5 stars
$250.90
+1.6%
$324.25
+29.2%
-10.6%$6.72B$2.57B-3.297,700Positive News
Analyst Upgrade
MTD
Mettler-Toledo International
4.3297 of 5 stars
$1,175.56
-0.8%
$1,300.36
+10.6%
-11.7%$24.43B$3.87B29.3218,000Positive News
Analyst Forecast
WAT
Waters
4.5305 of 5 stars
$349.93
-0.7%
$388.00
+10.9%
+21.0%$20.82B$2.96B31.758,200Trending News
Analyst Upgrade
ILMN
Illumina
4.871 of 5 stars
$95.41
+0.7%
$127.39
+33.5%
-10.5%$15.10B$4.37B-15.729,030Positive News
Analyst Forecast
TECH
Bio-Techne
4.9662 of 5 stars
$51.45
-0.8%
$72.00
+39.9%
-27.9%$8.07B$1.16B62.743,100Positive News
CRL
Charles River Laboratories International
4.0501 of 5 stars
$151.64
+1.1%
$171.85
+13.3%
-22.9%$7.45B$4.05B-233.2920,100Positive News
Analyst Downgrade
BRKR
Bruker
4.755 of 5 stars
$41.20
-1.4%
$52.89
+28.4%
-33.1%$6.24B$3.45B79.2311,396
PACB
Pacific Biosciences of California
2.6478 of 5 stars
$1.24
-3.9%
$2.06
+66.2%
+12.2%$372.10M$154.01M-0.44730Gap Up
HBIO
Harvard Bioscience
4.1148 of 5 stars
$0.44
-4.3%
$3.00
+576.0%
-83.7%$19.62M$94.14M-0.34490
TMO
Thermo Fisher Scientific
4.9915 of 5 stars
$405.83
-0.6%
$604.05
+48.8%
-22.5%$153.20B$42.88B23.80125,000Positive News
Analyst Forecast
A
Agilent Technologies
4.7189 of 5 stars
$118.06
-0.9%
$140.92
+19.4%
-5.7%$33.54B$6.51B29.1518,100Positive News
Analyst Forecast

Related Companies and Tools


This page (NYSE:BIO) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners